Table 2. Architecture of electronic case-report forms for Seoul National University Prospectively Enrolled Registry for Prostate Cancer-Radical Prostatectomy (SUPER-PC-RP).
Name of form | Number of fields | Entering type | Description and examples |
---|---|---|---|
Study data & demographics | 39 | Once entering | Study number, basic demographics and bio-banking information |
Preop. characteristics | 54 | Once entering | Initial PSA, biopsy information, past medical, social and family history |
Preop. imaging | 19 | Once entering | Results of magnetic resonance imaging and bone scan |
Operation | 38 | Once entering | Details of surgery |
Pathology | 50 | Once entering | Final pathology details |
Postop. outcomes | 9 | Once entering | Short-term postoperative results such as duration of hospital stay, cystography and Foley catheter removal date |
Complication | 31 | Once entering | Intraoperative, immediate, 30 and 90 days complications |
Lab | 35 | Repeatedly entering | Laboratory results (except PSA) |
PSA | 202 | Revisingly entering | PSA results |
Medication & comorbidity | 22 | Repeatedly entering | Information of medication and comorbidity |
A/E | 62 | Repeatedly entering | Post-treatment adverse events |
IPSS | 14 | Repeatedly entering | International Prostate Symptom Score questionnaire |
EPIC-CP | 26 | Repeatedly entering | Expanded Prostate Cancer Index Composite for Clinical Practice questionnaire |
IIEF-5 | 9 | Repeatedly entering | International Index of Erectile Function-5 questionnaire |
EQ-5D-5L | 10 | Repeatedly entering | EuroQol health-related utility measurement tool |
CARE questionnaire | 35 | Repeatedly entering | Convalescence And Recovery Evaluation questionnaire |
G8 | 10 | Once entering | Geriatric assessment by the G8 |
InBody | 26 | Repeatedly entering | Body composition measurement by bio-electrical impedance analysis |
Functional outcome summary | 30 | Revisingly entering | Summarized results of continence and potency |
Oncologic outcome summary | 63 | Revisingly entering | Adjuvant or salvage treatment and oncologic outcome results |
Preop., preoperative; postop., postoperative; PSA, prostate-specific antigen.